Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2017.05.006
Abstract: Immune checkpoint inhibitors (ICI) have shown great promise in a wide spectrum of adult solid and hematological malignancies, achieving objective tumor responses and prolonging survival. However, there is limited clinical success amongst pediatric patients. In… read more here.
Keywords: immune checkpoint; pediatric malignancies; checkpoint inhibitors; opportunities immune ... See more keywords